The FDA has approved Vykat XR (diazoxide choline) for the treatment of hyperphagia in adults and pediatric patients 4 years ...

The FDA has approved Blujepa (gepotidacin) for the treatment of female patients 12 years of age and older weighing at least 40kg with uncomplicated UTI.

Midlife cardiometabolic profiles were differentially associated with risk for early- and late-onset dementia regardless of genetic predisposition.

Up to 30% of acute kidney injury (AKI) survivors require dialysis and personalized care after discharge from the hospital.

GLP-1 receptor agonists were associated with improved survival and reduced graft loss among kidney transplant recipients with type 2 diabetes.

Severity of cardiometabolic comorbidity burden affects risk for all-cause hospitalization in patients with heart failure.

The Trump administration will lay off 10,000 workers at the US Department of Health and Human Services as part of a major reorganization.